Biocon Canmab 150 mg Trastuzumab Injection

Name: Biocon Canmab 150 mg Trastuzumab Injection
Brand: Welox Pharma Private Limited
Price: 9000 INR
Availability: InStock

Price 9000 INR/ Box

Get a Price/Quote

MOQ : 100 Boxes

Biocon Canmab 150 mg Trastuzumab Injection Specification

Dosage Form
Injection

Salt Composition
Trastuzumab 150 mg

Indication
Breast cancer treatment

Feature
Recombinant monoclonal antibody

Ingredients
Trastuzumab

Application
Human use, oncology

Physical Color/Texture
White to off-white lyophilized powder

Storage Instructions
Store at 2C-8C, do not freeze

Shelf Life
24 months

Form
Injection

Packaging Type
Vial

Target
HER2 receptor

Marketed In
India

Brand Name
Canmab

Reconstitution Required
Yes

Manufactured By
Biocon

Strength
150 mg

Route of Administration
Intravenous

Dosage
As directed by physician

Prescription/Non prescription
Prescription

Type
Biological therapy

Biocon Canmab 150 mg Trastuzumab Injection Trade Information

Minimum Order Quantity
100 Boxes

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Boxes Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

About Biocon Canmab 150 mg Trastuzumab Injection

Introducing Biocon Canmab 150 mg Trastuzumab Injection-a must-have paragon of oncology therapeutics that offers prodigious value for breast cancer treatment. This superior, prescription-only, recombinant monoclonal antibody specifically targets the HER2 receptor, ensuring a tailored and effective therapeutic approach. Designed for intravenous administration, each vial contains a white to off-white lyophilized powder requiring reconstitution. With a shelf life of 24 months, Canmab's formulation upholds the highest standards of safety and reliability. Jump on this advanced biological therapy, exclusively manufactured and marketed in India by Biocon.

Essential Features and Clinical Applications

Biocon Canmab 150 mg Trastuzumab Injection stands out as a superior solution in the domain of oncology, specifically formulated for HER2-positive breast cancer treatment. Its unique recombinant monoclonal antibody material ensures selective targeting, offering maximum therapeutic advantage. Designed only for intravenous use, it's a must-have for physicians aiming for optimal patient outcomes. The injection's prodigious effectiveness and safety profile make it indispensable in contemporary cancer management protocols.

Certifications, Samples, and Competitive Pricing

Biocon Canmab 150 mg Trastuzumab Injection is meticulously certified and meets stringent quality regulations, ensuring confidence and trust. For those considering bulk orders, samples are available upon request, facilitating thorough evaluation. With the lowest price ensured through FOB port arrangements, buyers can jump on generous sale price offers, and flexible exchange policies back every purchase. Leverage these unbeatable commercial conditions for maximum value and peace of mind.

FAQ's of Biocon Canmab 150 mg Trastuzumab Injection:

Q: How is Biocon Canmab 150 mg Trastuzumab Injection administered?

A: Canmab is administered intravenously after reconstitution by a qualified healthcare professional, as directed by the prescribing physician.

Q: What is the specific use of Biocon Canmab 150 mg Trastuzumab Injection?

A: This injection is indicated for the treatment of HER2-positive breast cancer patients, providing targeted biological therapy to improve outcomes.

Q: When should Canmab 150 mg be stored and handled with caution?

A: Canmab should be stored at 2C to 8C in its original packaging, avoiding freezing and direct sunlight, and handled only by trained personnel.

Q: Where is Biocon Canmab 150 mg available and marketed?

A: Biocon Canmab is manufactured and marketed across India, and available through authorized medical suppliers and pharmacies with a valid prescription.

Q: What is the process for preparing and using Canmab 150 mg?

A: The lyophilized powder requires reconstitution with a compatible solution before intravenous administration, ideally performed by healthcare professionals following the manufacturer's instructions.

Q: What is the main advantage of using Canmab over other therapies?

A: Canmab delivers a superior targeted approach against HER2-positive tumors, supported by high-quality manufacturing and a prodigious safety profile.